Additional analysis revealed that most Class-II transcripts were expressed from protein-coding genes, including the well-characterized breast cancer genes ERBB2 and MKI67, while most Class-I transcripts were novel lincRNAs whose function and significance in breast cancer had not been previously characterized. This evidence concerns the gene ERBB2 and breast cancer.